BARMER Wirkstoff Olmesartanmedoxomil und Hydrochlorothiazid ATC WHO: C09DA08

Buyer

Kaufmännische Krankenkasse - KKH

Winners

PUREN Pharma GmbH & Co. KG, Vivanta Generics s.r.o.

Contract value

no value published

Bids received

6

Published

18 May 2026

Awarded

19 Dec 2025

Contract start

19 Dec 2025

Sector

Medical equipment and pharmaceuticals

Region

Niedersachsen (DE929)

Source

Original notice on TED (341969-2026)

More awards from this buyer